1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Hypertension Drug Market
3.2. Opportunities in the Hypertension Drug Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Hypertension Drug Market, by Analysis
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Pulmonary Hypertension Drugs
5.4. Systemic Hypertension Drugs
6. Global Hypertension Drug Market, by Therapy
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Alpha Blockers
6.4. Angiotensin Converting Enzyme Inhibitor
6.5. Angiotensin Receptor Blockers
6.6. Beta Blockers Vasodilators
6.7. Calcium Channel Blockers
6.8. Diuretics
6.9. Renin Inhibitors
7. Global Hypertension Drug Market, by Distribution
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospital Pharmacy
7.4. Online Pharmacy
7.5. Retail Pharmacy
8. Global Hypertension Drug Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for Global Hypertension Drug Market
9.2. Market Vendor Ranking Analysis for Global Hypertension Drug Market
9.3. Competitive News Feed Analysis for Global Hypertension Drug Market
10. Company Usability Profiles
10.1. AstraZeneca plc
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Daiichi Sankyo Company, Ltd.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Novartis AG
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Pfizer, Inc.
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. United Therapeutics Corporation
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details